Ettore Strumia

Title: Ettore Strumia: Innovator in Cardiac and Respiratory Treatments

Introduction

Ettore Strumia is a notable inventor based in Turin, Italy. He has made significant contributions to the field of medicine, particularly in the development of treatments for cardiac and respiratory insufficiencies. With a total of 2 patents to his name, Strumia's work has the potential to impact patient care positively.

Latest Patents

Strumia's latest patents include innovative uses of creatine and phosphocreatine. The first patent describes a new application of creatine in the preparation of a drug aimed at treating cardiac and/or respiratory insufficiency. The second patent focuses on a solution for infusion that employs phosphocreatine as an active ingredient. This solution is intended for the treatment of acute myocardial infarction and serves as a myocardium protecting agent during open-heart surgery.

Career Highlights

Throughout his career, Ettore Strumia has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Monsanto Italiano S.p.a. and Schiapparelli Farmaceutici S.p.a. His experience in these organizations has contributed to his expertise in developing innovative medical solutions.

Collaborations

Strumia has collaborated with various professionals in his field, including Marco Anelli. These partnerships have likely enhanced his research and development efforts, leading to the successful creation of his patents.

Conclusion

Ettore Strumia's contributions to medical innovation, particularly in cardiac and respiratory treatments, highlight his role as a significant inventor. His patents reflect a commitment to improving patient outcomes through scientific advancements.